GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » 5-Year EBITDA Growth Rate

Sonoscape Medical (SZSE:300633) 5-Year EBITDA Growth Rate : 36.40% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical 5-Year EBITDA Growth Rate?

Sonoscape Medical's EBITDA per Share for the three months ended in Sep. 2024 was ¥-0.14.

During the past 12 months, Sonoscape Medical's average EBITDA Per Share Growth Rate was -48.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 531.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 36.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sonoscape Medical was 531.50% per year. The lowest was -79.50% per year. And the median was 8.00% per year.


Competitive Comparison of Sonoscape Medical's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Sonoscape Medical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoscape Medical's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonoscape Medical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sonoscape Medical's 5-Year EBITDA Growth Rate falls into.



Sonoscape Medical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Sonoscape Medical  (SZSE:300633) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Sonoscape Medical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Executives
Zhou Wen Ping Directors, executives
Huang Yi Bo Directors, executives
Li Hao Directors, executives
Chen Zhi Qiang Director
Wu Kun Xiang Directors, executives
Liu Ying Fang Director

Sonoscape Medical Headlines

No Headlines